Home > Insider Trading > Filing (0001181431-13-017025)

Filing Details

Accession Number:: 0001181431-13-017025
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2013-03-14 17:53:17
Reporting Period:: 2013-03-11

Filing Date:: 2013-03-14
Accepted Time:: 2013-03-14 17:53:17
Original Submission Date:: 2013-03-13
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1484478	Furiex Pharmaceuticals Inc.	FURX	Pharmaceutical Preparations (2834)	271197863

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1106813	P Robert Ruscher	C/O Furiex Pharmaceuticals, Inc. 3900 Paramount Parkway, Suite 150 Morrisville NC 27560		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-03-11	5,930	$13.45	5,930	No	4	M	Direct
Common Stock	Acquisiton	2013-03-11	5,829	$13.94	11,759	No	4	M	Direct
Common Stock	Acquisiton	2013-03-11	11,806	$9.11	23,565	No	4	M	Direct
Common Stock	Disposition	2013-03-11	23,565	$41.74	0	No	4	S	Direct
Common Stock	Acquisiton	2013-03-12	1,073	$13.45	1,073	No	4	M	Direct
Common Stock	Acquisiton	2013-03-12	1,054	$13.94	2,127	No	4	M	Direct
Common Stock	Acquisiton	2013-03-12	2,135	$9.11	4,262	No	4	M	Direct
Common Stock	Disposition	2013-03-12	4,262	$40.71	0	No	4	S	Direct
Common Stock	Acquisiton	2013-03-13	1,822	$13.45	1,822	No	4	M	Direct
Common Stock	Acquisiton	2013-03-13	1,792	$13.94	3,614	No	4	M	Direct
Common Stock	Acquisiton	2013-03-13	3,629	$9.11	7,243	No	4	M	Direct
Common Stock	Disposition	2013-03-13	7,243	$39.96	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (to buy)	Disposition	2013-03-11	5,930	$0.00	5,930	$13.45
Common Stock	Stock Options (to buy)	Disposition	2013-03-11	5,829	$0.00	5,829	$13.94
Common Stock	Stock Options (to buy)	Disposition	2013-03-11	11,806	$0.00	11,806	$9.11
Common Stock	Stock Options (to buy)	Disposition	2013-03-12	1,073	$0.00	1,073	$13.45
Common Stock	Stock Options (to buy)	Disposition	2013-03-12	1,054	$0.00	1,054	$13.94
Common Stock	Stock Options (to buy)	Disposition	2013-03-12	2,135	$0.00	2,135	$9.11
Common Stock	Stock Options (to buy)	Disposition	2013-03-13	1,822	$0.00	1,822	$13.45
Common Stock	Stock Options (to buy)	Disposition	2013-03-13	1,792	$0.00	1,792	$13.94
Common Stock	Stock Options (to buy)	Disposition	2013-03-13	3,629	$0.00	3,629	$9.11

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2,895	2021-10-12	No	4	M	Direct
2,846	2021-05-19	No	4	M	Direct
5,764	2020-06-17	No	4	M	Direct
1,822	2021-10-12	No	4	M	Direct
1,792	2021-05-19	No	4	M	Direct
3,629	2020-06-17	No	4	M	Direct
0	2021-10-12	No	4	M	Direct
0	2021-05-19	No	4	M	Direct
0	2020-06-17	No	4	M	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Options (to buy)	$18.22		2022-05-24	17,500	17,500	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2022-05-24	17,500	17,500	Direct

Footnotes

These options and underlying shares were previously incorrectly reported as 8,825 in the Form 4.
These options and underlying shares were previously incorrectly reported as 8,675 in the Form 4.
These options and undelrying shares were previously inccorectly reported as 17,570 in the Form 4.
This exercise of options were previously incorrectly reported as being included in the 8,825 referenced in footnote (1).
This exercise of options were previously incorrectly reported as being included in the 8,675 referenced in footnote (2).
This exercise of options were previously incorrectly reported as being included in the 17,570 referenced in footnote (3).
The options were awarded on 10/12/2011 and vest and become exercisable in full on the earlier of 5/19/2012 or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
The options were awarded on 5/19/2011 and vest and become exercisable in full on the earlier of the first anniversary of the date of grant or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
The options were awarded on 6/17/2010 and vest and become exercisable in full on the earlier of the first anniversary of the date of grant or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
The options were awarded on 5/24/2012 and vest and become exercisable in full on the earlier of 5/24/2013 or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.